Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001513160-12-000013
Filing Date
2012-02-21
Accepted
2012-02-21 10:53:07
Documents
10
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDED ANNUAL REPORT annualreport123111amend.htm 10-K/A 145121
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER ex31a.htm EX-31.A 10181
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31b.htm EX-31.B 9890
4 SECTION 1350 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND CHIEF FINANCIAL OF ex32.htm EX-32 10101
  Complete submission text file 0001513160-12-000013.txt   1355066

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT pars-20111231.xml EX-101.INS 149605
6 XBRL TAXONOMY EXTENSION SCHEMA pars-20111231.xsd EX-101.SCH 13597
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pars-20111231_cal.xml EX-101.CAL 21747
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pars-20111231_def.xml EX-101.DEF 8518
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pars-20111231_lab.xml EX-101.LAB 110886
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pars-20111231_pre.xml EX-101.PRE 74494
Mailing Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830
Business Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830 7324529556
PHARMOS CORP (Filer) CIK: 0000713275 (see all company filings)

EIN.: 363207413 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-11550 | Film No.: 12625464
SIC: 2834 Pharmaceutical Preparations